
CAN-2409/EBRT Improves Disease-Free Survival in Localized Prostate Cancer
CAN-2409, a localized cytolytic mechanism, administered locally and combined with an oral prodrug significantly enhanced disease-free survival (DFS) outcomes vs placebo when added to standard-of-care (SOC) external beam radiation therapy (EBRT) in patients …